Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,148,142 papers from all fields of science
Search
Sign In
Create Free Account
Lactobacillus reuteri 100000000 UNT Chewable Tablet
Known as:
Lactobacillus reuteri 100 Million Cells Chewable Tablet
, Lactobacillus reuteri 100 Million UNT Chewable Tablet
, Lactobacillus reuteri 100,000,000 UNT Chewable Tablet
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Chewable Tablet
Narrower (2)
Lactobacillus reuteri 100000000 UNT Chewable Tablet [BioGaia]
Lactobacillus reuteri 100000000 UNT Chewable Tablet [Pedia-Lax Probiotic]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: a randomized clinical trial…
C. Tenorio-Jiménez
,
M. Martínez-Ramírez
,
+9 authors
C. Gómez-Llorente
BMC Complementary and Alternative Medicine
2018
Corpus ID: 53745542
BackgroundObesity is characterized by increased fat mass and is associated with the development of insulin resistance syndrome…
Expand
Review
2018
Review
2018
Lactobacillus reuteri to Treat Infant Colic: A Meta-analysis
V. Sung
,
F. D'Amico
,
+10 authors
D. Tancredi
Pediatrics
2018
Corpus ID: 23157296
Lactobacillus reuteri DSM17938 effectively reduces crying in breastfed infants with colic; these are the most definitive…
Expand
Highly Cited
2012
Highly Cited
2012
Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial
M. L. Jones
,
C. Martoni
,
S. Prakash
European Journal of Clinical Nutrition
2012
Corpus ID: 19663923
Background/Objectives:The percentage of hypercholesterolemic individuals not reaching their LDL-cholesterol (LDL-C) goal remains…
Expand
Highly Cited
2012
Highly Cited
2012
Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis
S. Oliva
,
G. Di Nardo
,
+5 authors
L. Stronati
Alimentary Pharmacology and Therapeutics
2012
Corpus ID: 37429715
Background Intestinal microbiota manipulation, one of the pathogenetic components of inflammatory bowel disease (IBD), has…
Expand
Highly Cited
2012
Highly Cited
2012
Lactobacillus reuteri Prevents Diet-Induced Obesity, but not Atherosclerosis, in a Strain Dependent Fashion in Apoe−/− Mice
F. Fåk
,
F. Bäckhed
PLoS ONE
2012
Corpus ID: 17388025
Objective To investigate whether the specific strains of Lactobacillus reuteri modulates the metabolic syndrome in Apoe−/− mice…
Expand
Highly Cited
2011
Highly Cited
2011
Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults
M. Jones
,
C. Martoni
,
Mathieu Parent
,
S. Prakash
British Journal of Nutrition
2011
Corpus ID: 24590632
Several studies have reported limited or no reduction in serum cholesterol in response to probiotic formulations. Recently…
Expand
Highly Cited
2007
Highly Cited
2007
Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial.
T. Abrahamsson
,
T. Jakobsson
,
+4 authors
G. Oldaéus
Journal of Allergy and Clinical Immunology
2007
Corpus ID: 20830002
Highly Cited
2006
Highly Cited
2006
Salivary mutans streptococci and lactobacilli levels after ingestion of the probiotic bacterium Lactobacillus reuteri ATCC 55730 by straws or tablets
E. Çaglar
,
Sule Kavaloglu Cildir
,
S. Ergeneli
,
N. Sandalli
,
S. Twetman
Acta Odontologica Scandinavica
2006
Corpus ID: 24362248
Objective. Previous studies have suggested that lactobacilli-derived probiotics in dairy products may affect oral ecology, but…
Expand
Highly Cited
2005
Highly Cited
2005
Increasing work-place healthiness with the probiotic Lactobacillus reuteri: A randomised, double-blind placebo-controlled study
Py Tubelius
,
V. Stan
,
A. Zachrisson
Environmental Health
2005
Corpus ID: 8242617
BackgroundShort term illnesses, usually caused by respiratory or gastrointestinal diseases are disruptive to productivity and…
Expand
1992
1992
Transformation ofLactobacillus reuteri with electroporation: Studies on the erythromycin resistance plasmid pLUL631
S. Ahrné
,
G. Molin
,
L. Axelsson
Current Microbiology
1992
Corpus ID: 35846409
A high-frequency transformation system was developed forLactobacillus reuteri with the electroporation technique. With this…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE